(Q36641208)

15 August 2017

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer (English)

1 reference

15 August 2017

1 reference

1 reference

Keum JS

1

1 reference

15 August 2017

Kong G

2

1 reference

15 August 2017

Yang SC

3

1 reference

15 August 2017

Shin DH

4

1 reference

15 August 2017

Park SS

5

1 reference

15 August 2017

Lee JH

6

1 reference

15 August 2017

Lee JD

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

81

1 reference

15 August 2017

1

1 reference

15 August 2017

127-132

1 reference

Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Amplification at chromosome 11q13 in transitional cell tumours of the bladder.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Determination of the prognostic value of cyclin D1 overexpression in breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2374356

Mutations of the p53 Gene as a Predictor of Poor Prognosis in Patients With Non-Small-Cell Lung Cancer

21 October 2018

1 reference

12 December 2020

Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining

1 reference

12 December 2020

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma

1 reference

12 December 2020

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

1 reference

12 December 2020

Amplification and expression of the human cyclin D gene in esophageal cancer

1 reference

12 December 2020

Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma

1 reference

12 December 2020

1 reference

12 December 2020

Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma

1 reference

12 December 2020

Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas

1 reference

12 December 2020

PRAD-1/cyclin D1 gene amplification correlates with messenger RNA overexpression and tumor progression in human laryngeal carcinomas

1 reference

12 December 2020

Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis

1 reference

12 December 2020

Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck

1 reference

12 December 2020

Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry

1 reference

12 December 2020

Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene

1 reference

12 December 2020

The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer

1 reference

12 December 2020

Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis

1 reference

12 December 2020

Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression

1 reference

12 December 2020

Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation

1 reference

12 December 2020

Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis

1 reference

12 December 2020

Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients

1 reference

12 December 2020

Prognosis and survival in resected lung carcinoma based on the new international staging system

1 reference

12 December 2020

Oesophageal cancer and amplification of the human cyclin D gene CCND1/PRAD1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690661

7 January 2021

PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690661

7 January 2021

A new international staging system for lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690661

7 January 2021

bcl-2 protein in non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6690661

7 January 2021

Identifiers

DOI

10.1038/SJ.BJC.6690661

1 reference

release_ms7oxzkhm5eq7prf3nndkz477q

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ms7oxzkhm5eq7prf3nndkz477q

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

10487623

1 reference